(R)-tert-Butyl (morpholin-3-ylmethyl)carbamate is primarily utilized in the field of organic synthesis, particularly in the development of pharmaceutical compounds. Its structure, featuring a morpholine ring and a carbamate group, makes it a valuable intermediate in the synthesis of biologically active molecules. It is often employed in the preparation of chiral compounds, where its stereochemistry plays a crucial role in achieving the desired enantioselectivity. This chemical is also used in the design of drug candidates targeting various diseases, including central nervous system disorders, due to its ability to modulate specific biological pathways. Additionally, it serves as a building block in the creation of complex molecules for medicinal chemistry research, enabling the exploration of new therapeutic agents.